Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Adaptive Biotechnologies Corporation    ADPT

ADAPTIVE BIOTECHNOLOGIES CORPORATION

(ADPT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

ADAPTIVE BIOTECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits (form 8-K)

08/21/2020 | 05:25pm EST
Item 8.01 Other Events.



On August 21, 2020, Adaptive Biotechnologies Corporation (the "Company") filed a prospectus supplement to its Form S-3 shelf registration statement, filed with the Securities and Exchange Commission on July 14, 2020. The prospectus supplement relates to the registration of up to 33,493,708 shares of the Company's common stock held by the selling shareholder identified in the prospectus supplement (the "Shares"). The Company will not offer any newly issued shares or receive any proceeds from the sale of the Shares by the selling shareholder, and the registration of the Shares for resale does not impact the total number of shares of the Company's common stock that are outstanding.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



                   Exhibit              Description
                   Number
                   5.1         Opinion of DLA Piper LLP (US)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about ADAPTIVE BIOTECHNOLOGIES CORPORATION
11/24ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A..
AQ
11/23ADAPTIVE BIOTECHNOLOGIES : and Collaborators to Present Data from More Than 35 A..
AQ
11/23Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 ..
GL
11/16ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-..
AQ
11/13ADAPTIVE BIOTECHNOLOGIES : Preliminary Data from Real-World Study Demonstrate T-..
AQ
11/13Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms..
GL
11/12ADAPTIVE BIOTECHNOLOGIES CORP : Other Events (form 8-K)
AQ
11/10ADAPTIVE BIOTECHNOLOGIES : Management's Discussion and Analysis of Financial Con..
AQ
11/10ADAPTIVE BIOTECHNOLOGIES CORP : Results of Operations and Financial Condition, F..
AQ
11/10ADAPTIVE BIOTECHNOLOGIES : 3Q Earnings Snapshot
AQ
More news